AKT1 and endothelial dysfunction: Considering that there is a significant association between endothelial dysfunction and insulin resistance, insulin sensitizers are anticipated to ameliorate endothelial function through restoring PI3-kinase/Akt/eNOS pathway and increasing NO production.